Literature DB >> 27531073

Increased PI3K/Akt activity and deregulated humoral immune response in human PTEN deficiency.

Gertjan J Driessen1, Hanna IJspeert2, Marjolein Wentink2, Helger G Yntema3, P Martin van Hagen2, Arthur van Strien2, Giorgia Bucciol4, Ozgur Cogulu5, Margreet Trip2, Willy Nillesen3, Els A Peeters6, Ingrid Pico-Knijnenburg2, Barbara H Barendregt2, Marta Rizzi7, Jacques J van Dongen2, Necil Kutukculer8, Mirjam van der Burg9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27531073     DOI： 10.1016/j.jaci.2016.07.010

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  19 in total

Review 1.  Immune Dysregulation and Disease Pathogenesis due to Activating Mutations in PIK3CD-the Goldilocks' Effect.

Authors:  Stuart G Tangye; Julia Bier; Anthony Lau; Tina Nguyen; Gulbu Uzel; Elissa K Deenick
Journal:  J Clin Immunol       Date:  2019-03-25       Impact factor: 8.317

Review 2.  The role of monogenic disease in children with very early onset inflammatory bowel disease.

Authors:  Judith R Kelsen; Robert N Baldassano
Journal:  Curr Opin Pediatr       Date:  2017-10       Impact factor: 2.856

Review 3.  Genomic and Immunologic Drivers of Very Early-Onset Inflammatory Bowel Disease.

Authors:  Maire A Conrad; Judith R Kelsen
Journal:  Pediatr Dev Pathol       Date:  2019-03-06

4.  PTEN in propofol-induced insulin resistance in mouse primary hepatocytes.

Authors:  Long Zhou; Lilin Wang; Xuhuai Hu; Yuantao Li
Journal:  Exp Ther Med       Date:  2018-10-01       Impact factor: 2.447

Review 5.  Phosphoinositide-3-Kinase Signaling in Human Natural Killer Cells: New Insights from Primary Immunodeficiency.

Authors:  Emily M Mace
Journal:  Front Immunol       Date:  2018-03-07       Impact factor: 7.561

6.  Enhanced AKT Phosphorylation of Circulating B Cells in Patients With Activated PI3Kδ Syndrome.

Authors:  Takaki Asano; Satoshi Okada; Miyuki Tsumura; Tzu-Wen Yeh; Kanako Mitsui-Sekinaka; Yuki Tsujita; Youjiro Ichinose; Akira Shimada; Kunio Hashimoto; Taizo Wada; Kohsuke Imai; Osamu Ohara; Tomohiro Morio; Shigeaki Nonoyama; Masao Kobayashi
Journal:  Front Immunol       Date:  2018-04-05       Impact factor: 7.561

Review 7.  Early-onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms.

Authors:  Julia Pazmandi; Artem Kalinichenko; Rico Chandra Ardy; Kaan Boztug
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

8.  Two Monogenetic Disorders, Activated PI3-Kinase-δ Syndrome 2 and Smith-Magenis Syndrome, in One Patient: Case Report and a Literature Review of Neurodevelopmental Impact in Primary Immunodeficiencies Associated With Disturbed PI3K Signaling.

Authors:  Nidia Moreno-Corona; Loïc Chentout; Lucie Poggi; Romane Thouenon; Cecile Masson; Melanie Parisot; Lou Le Mouel; Capucine Picard; Isabelle André; Marina Cavazzana; Laurence Perrin; Anne Durandy; Saba Azarnoush; Sven Kracker
Journal:  Front Pediatr       Date:  2021-06-24       Impact factor: 3.418

Review 9.  Epstein-Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency.

Authors:  Jean-Marie Carpier; Carrie L Lucas
Journal:  Front Immunol       Date:  2018-01-16       Impact factor: 7.561

Review 10.  "Immune TOR-opathies," a Novel Disease Entity in Clinical Immunology.

Authors:  Sophie Jung; Laura Gámez-Díaz; Michele Proietti; Bodo Grimbacher
Journal:  Front Immunol       Date:  2018-05-09       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.